Performant Healthcare Surges 18% in Q2 Revenue, Returns to Profitability

TL;DR

**Performant Healthcare is back in the black with strong revenue growth, making it a compelling buy for a turnaround play.**

AI Summary

Performant Healthcare Inc. reported a significant increase in revenue for the three months ended June 30, 2025, reaching $35.2 million, up from $29.8 million in the prior-year period, representing an 18.1% increase. For the six months ended June 30, 2025, total revenue grew to $68.5 million from $59.1 million, a 15.9% rise. The company's net income for the second quarter of 2025 was $2.5 million, a substantial improvement from a net loss of $0.8 million in the same period of 2024. This positive shift was primarily driven by increased revenue in both the Eligibility-Based and Claims-Based segments, which saw revenues of $15.8 million and $19.4 million respectively for Q2 2025. The strategic outlook appears positive, with the company demonstrating strong operational performance and improved profitability, reducing its accumulated deficit to $10.2 million as of June 30, 2025, from $12.7 million at December 31, 2024. The company's focus on healthcare cost containment and recovery services continues to drive its financial performance.

Why It Matters

Performant Healthcare's return to profitability and robust revenue growth of 18.1% in Q2 2025 signals a strong operational turnaround, which is crucial for investor confidence. This performance suggests effective execution in the competitive healthcare cost containment market, potentially attracting new institutional investors. For employees, sustained profitability could lead to job security and growth opportunities within the company. Customers benefit from Performant's enhanced ability to deliver on its services, as financial stability often translates to better service quality and innovation. In the broader market, Performant's success highlights the increasing demand for specialized healthcare administrative services, potentially putting pressure on competitors to innovate and improve their own offerings.

Risk Assessment

Risk Level: medium — While Performant Healthcare Inc. showed strong revenue growth and returned to profitability, the company still carries an accumulated deficit of $10.2 million as of June 30, 2025. This indicates historical losses that could resurface if market conditions or operational efficiencies decline. Furthermore, the healthcare sector is subject to significant regulatory changes and competitive pressures, which could impact future revenue streams and profitability, despite the current positive trend.

Analyst Insight

Investors should consider initiating a position in Performant Healthcare Inc. given its strong Q2 2025 performance, including an 18.1% revenue increase and a return to net income. Monitor future filings for continued reduction of the accumulated deficit and sustained growth in both Eligibility-Based and Claims-Based segments to confirm the turnaround's durability.

Financial Highlights

revenue

$35.2M

net Income

$2.5M

revenue Growth

+18.1%

Revenue Breakdown

Key Numbers

• $35.2M — Q2 2025 Revenue (Increased by 18.1% from Q2 2024)
• $2.5M — Q2 2025 Net Income (Shifted from a $0.8M net loss in Q2 2024)
• 18.1% — Q2 Revenue Growth (Year-over-year increase for the quarter ended June 30, 2025)
• $68.5M — YTD 2025 Revenue (Increased by 15.9% from YTD 2024)
• $10.2M — Accumulated Deficit (Reduced from $12.7M at December 31, 2024)
• $15.8M — Eligibility-Based Revenue Q2 2025 (Contributed to overall revenue growth)
• $19.4M — Claims-Based Revenue Q2 2025 (Contributed to overall revenue growth)

Key Players & Entities

• Performant Healthcare Inc. (company) — filer of the 10-Q
• $35.2 million (dollar_amount) — total revenue for Q2 2025
• $29.8 million (dollar_amount) — total revenue for Q2 2024
• $68.5 million (dollar_amount) — total revenue for the six months ended June 30, 2025
• $59.1 million (dollar_amount) — total revenue for the six months ended June 30, 2024
• $2.5 million (dollar_amount) — net income for Q2 2025
• $0.8 million (dollar_amount) — net loss for Q2 2024
• $10.2 million (dollar_amount) — accumulated deficit as of June 30, 2025
• $12.7 million (dollar_amount) — accumulated deficit as of December 31, 2024
• SEC (regulator) — recipient of the 10-Q filing

FAQ

Industry Context

Performant Healthcare Inc. operates in the healthcare cost containment and recovery services sector. This industry is characterized by a focus on optimizing revenue cycles, reducing healthcare expenditures, and ensuring compliance with complex regulatory frameworks. Key trends include the increasing adoption of technology for data analytics and automation in claims processing and eligibility verification.

Regulatory Implications

The company's operations are subject to healthcare regulations, including those related to data privacy (e.g., HIPAA) and government program compliance. Changes in healthcare policy or reimbursement rules could impact revenue streams and operational costs. Adherence to these regulations is critical for maintaining business operations and client trust.

What Investors Should Do

1. Monitor segment performance
2. Analyze reduction in accumulated deficit
3. Evaluate competitive positioning

Key Dates

• 2025-06-30: End of Second Quarter 2025 — Reported total revenue of $35.2 million and net income of $2.5 million. Accumulated deficit reduced to $10.2 million.
• 2024-06-30: End of Second Quarter 2024 — Reported total revenue of $29.8 million and a net loss of $0.8 million.
• 2025-08-07: Filing Date for 10-Q — Indicates the official reporting of financial results for the period ending June 30, 2025.

Glossary

Accumulated Deficit

The cumulative net losses of a company that have not been offset by net income or other gains. (A reduction in the accumulated deficit, as seen by Performant Healthcare Inc., indicates improving profitability over time.)

Eligibility-Based Revenue

Revenue generated from services that determine a healthcare provider's eligibility for certain payments or reimbursements. (A key segment contributing to Performant Healthcare Inc.'s overall revenue growth.)

Claims-Based Revenue

Revenue derived from the process of submitting, managing, and recovering payments for healthcare claims. (A key segment contributing to Performant Healthcare Inc.'s overall revenue growth.)

Year-Over-Year Comparison

Performant Healthcare Inc. demonstrated significant year-over-year improvement in its Q2 2025 results compared to Q2 2024. Total revenue increased by 18.1% to $35.2 million, a substantial jump from $29.8 million. Crucially, the company shifted from a net loss of $0.8 million in the prior year's second quarter to a net income of $2.5 million, indicating improved operational efficiency and profitability. The accumulated deficit also saw a reduction, signaling a positive trajectory towards financial health.

Filing Documents

• pfmt-20250630.htm (10-Q) — 816KB
• ex063025311cert.htm (EX-31.1) — 9KB
• ex063025312cert.htm (EX-31.2) — 9KB
• ex063025321cert.htm (EX-32.1) — 5KB
• ex063025322cert.htm (EX-32.2) — 5KB
• 0001550695-25-000072.txt ( ) — 4189KB
• pfmt-20250630.xsd (EX-101.SCH) — 28KB
• pfmt-20250630_cal.xml (EX-101.CAL) — 51KB
• pfmt-20250630_def.xml (EX-101.DEF) — 97KB
• pfmt-20250630_lab.xml (EX-101.LAB) — 462KB
• pfmt-20250630_pre.xml (EX-101.PRE) — 295KB
• pfmt-20250630_htm.xml (XML) — 375KB

—Financial Information

PART I—Financial Information Item 1. Consolidated Financial Statements Consolidated Balance Sheets — June 30, 2025 (unaudited) and December 31, 2024 1 Consolidated Statements of Operations — Three and Six Months Ended June 30, 2025 and 2024 (unaudited) 2 Consolidated Statements of Changes in Stockholders' Equity — Three and Six Months Ended June 30, 2025 and 2024 (unaudited) 3 Consolidated Statements of Cash Flows — Six Months Ended June 30, 2025 and 2024 (unaudited) 4 Condensed Notes to Consolidated Financial Statements (unaudited) 5 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 14 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 26 Item 4. Disclosure Controls and Procedures 26

—Other Information

PART II—Other Information 27 Item 1.

Legal Proceedings

Legal Proceedings 27 Item 1A.

Risk Factors

Risk Factors 27 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 38

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 38

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 38

Other Information

Item 5. Other Information 38 Item 6. Exhibits 39

Signatures

Signatures 40 i Table of Contents PERFORMANT HEALTHCARE, INC. AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except par value amounts) June 30, 2025 December 31, 2024 (Unaudited) Assets Current assets: Cash and cash equivalents $ 9,076 $ 9,292 Trade accounts receivable, net of $ 0 allowance for credit losses 17,746 14,165 Contract assets, net of $ 0 allowance for credit losses 17,105 10,876 Prepaid expenses and other current assets 3,565 3,991 Income tax receivable — 34 Total current assets 47,492 38,358 Property, equipment, and software, net 13,862 14,021 Goodwill 47,372 47,372 Debt issuance costs 303 416 Right-of-use assets 1,063 826 Other assets 863 781 Total assets $ 110,955 $ 101,774 Liabilities and Stockholders' Equity Current liabilities: Accrued salaries and benefits $ 11,868 $ 8,502 Accounts payable 1,070 482 Other current liabilities 2,129 2,091 Income taxes payable 229 — Contract liabilities 359 753 Estimated liability for appeals and disputes 600 517 Deferred asset acquisition payments 1,190 1,243 Lease liabilities 536 383 Total current liabilities 17,981 13,971 Long-term loan payable 8,000 8,000 Deferred asset acquisition payments 2,095 2,686 Lease liabilities 546 462 Other liabilities 95 156 Total liabilities 28,717 25,275 Commitments and contingencies Stockholders' equity: Common stock, $ 0.0001 par value. Authorized, 500,000 shares at June 30, 2025 and December 31, 2024 respectively; issued and outstanding 78,997 and 78,309 shares at June 30, 2025 and December 31, 2024, respectively 8 8 Additional paid-in capital 155,430 151,688 Accumulated deficit ( 73,200 ) ( 75,197 ) Total stockholders' equity 82,238 76,499 Total liabilities and stockholders' equity $ 110,955 $ 101,774 See accompanying condensed notes to consolidated financial statements. 1 Table of Contents PERFORMANT HEALTHCARE, INC. AND SUBSIDIARIES Consolidated Statements of Operations (In thousands, except per sha

View Full Filing

View this 10-Q filing on SEC EDGAR